Use of esmolol to control bleeding and heart rate during electroconvulsive therapy in a patient with an intracranial aneurysm

Electroconvulsive therapy (ECT) is a commonly used treatment modality for patients with major affective disorders that are unresponsive to pharmacological therapy. While ECT has been shown to be a very safe treatment, it is associated with transient hemodynamic alterations, including hypertension, w...

Full description

Saved in:
Bibliographic Details
Published inJournal of clinical anesthesia Vol. 9; no. 6; pp. 493 - 495
Main Authors Kolano, Jeffrey W., Chhibber, Ashwani, Calalang, Carolyn C.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.09.1997
Subjects
Adrenergic beta-Antagonists - therapeutic use
Aged
Aneurysm, cerebral
Cerebral Hemorrhage - drug therapy
Cerebral Hemorrhage - etiology
Electroconvulsive Therapy
esmolol
Female
Heart Rate - drug effects
Humans
Intracranial Aneurysm - complications
Intracranial Aneurysm - drug therapy
Propanolamines - therapeutic use
Aneurysm, cerebral
electroconvulsive therapy
esmolol
Online AccessGet full text

Cover

More Information
Summary:Electroconvulsive therapy (ECT) is a commonly used treatment modality for patients with major affective disorders that are unresponsive to pharmacological therapy. While ECT has been shown to be a very safe treatment, it is associated with transient hemodynamic alterations, including hypertension, which are associated with increased risk of rupture of an intracranial aneurysm. We describe our use of the ultrashort acting betablacker, esmolol, for blood-pressure control in a woman with known cerebral aneurysmal disease who required ECT for treatment of recurrent major depression.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:0952-8180
1873-4529
DOI:10.1016/S0952-8180(97)00074-3